XML 82 R3.htm IDEA: XBRL DOCUMENT v3.19.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 29, 2019
Jun. 30, 2019
[1]
ASSETS    
Cash and cash equivalents $ 4,607,182 $ 3,658,219
Investments 983,650 1,772,984
Accounts receivable, less allowance for doubtful accounts of $5,226 as of September 29, 2019, and $5,021 as of June 30, 2019 1,635,643 1,455,522
Inventories 1,483,385 1,540,140
Prepaid expenses and other current assets 124,755 133,544
Total current assets 8,834,615 8,560,409
Property and equipment, net 1,030,168 1,059,077
Restricted cash and investments 254,654 255,177
Goodwill 1,484,392 1,484,597
Intangible assets, net 206,256 216,950
Other assets 533,417 425,123
Total assets 12,343,502 12,001,333
LIABILITIES AND STOCKHOLDERS’ EQUITY    
Trade accounts payable 415,808 376,561
Accrued expenses and other current liabilities 990,035 946,641
Deferred profit 406,681 381,317
Current portion of long-term debt and finance lease obligations 645,158 667,131
Total current liabilities 2,457,682 2,371,650
Long-term debt and finance lease obligations, less current portion 3,788,089 3,822,768
Income taxes payable 856,895 892,790
Other long-term liabilities 261,890 190,821
Total liabilities 7,364,556 7,278,029
Commitments and contingencies
Temporary equity, convertible notes 42,553 49,439
Stockholders’ equity:    
Preferred stock, at par value of $0.001 per share; authorized, 5,000 shares, none outstanding 0 0
Common stock, at par value of $0.001 per share; authorized, 400,000 shares; issued and outstanding, 144,871 shares at September 29, 2019, and 144,433 shares at June 30, 2019 145 144
Additional paid-in capital 6,456,492 6,409,405
Treasury stock, at cost; 140,970 shares at September 29, 2019, and 140,573 shares at June 30, 2019 (11,680,689) (11,602,573)
Accumulated other comprehensive loss (72,560) (64,030)
Retained earnings 10,233,005 9,930,919
Total stockholders’ equity 4,936,393 4,673,865
Total liabilities and stockholders’ equity $ 12,343,502 $ 12,001,333
[1] Derived from audited financial statements